tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Citi says headlines could push consumers to alternatives to Kenvue’s Tylenol
PremiumThe FlyCiti says headlines could push consumers to alternatives to Kenvue’s Tylenol
8d ago
Texas sues Kenvue, Johnson & Johnson over Tylenol autism risk
Premium
The Fly
Texas sues Kenvue, Johnson & Johnson over Tylenol autism risk
8d ago
Clear Street sees ‘unmatched commercial promise’ for Protagonist’s icotrokinra
Premium
The Fly
Clear Street sees ‘unmatched commercial promise’ for Protagonist’s icotrokinra
9d ago
Johnson & Johnson announces findings from Phase 2 DAHLIAS study
PremiumThe FlyJohnson & Johnson announces findings from Phase 2 DAHLIAS study
12d ago
Johnson & Johnson announces results from Phase 3 ICONIC-TOTAL study
Premium
The Fly
Johnson & Johnson announces results from Phase 3 ICONIC-TOTAL study
12d ago
Nanobiotix provides update on JNJ-1900 after Johnson & Johnson transfer
Premium
The Fly
Nanobiotix provides update on JNJ-1900 after Johnson & Johnson transfer
12d ago
Johnson & Johnson announces new results from Phase 1b/2 OrigAMI-4 study
PremiumThe FlyJohnson & Johnson announces new results from Phase 1b/2 OrigAMI-4 study
17d ago
Citi cautious on Kenvue after talc lawsuit filed in UK
Premium
The Fly
Citi cautious on Kenvue after talc lawsuit filed in UK
20d ago
J&J faces first UK lawsuits over talc cancer allegations, Reuters reports
Premium
The Fly
J&J faces first UK lawsuits over talc cancer allegations, Reuters reports
20d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100